Trial Profile
Escitalopram for the treatment of obsessive compulsive disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 01 Nov 2009 Results reported in International Clinical Psychopharmacology.
- 16 Nov 2005 New trial record.